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Abstract
Dipyrone administered intravenously (iv) or intracerebroventricularly
(icv) delays gastric emptying (GE) in rats. Gamma-aminobutyric acid
(GABA) is the most potent inhibitory neurotransmitter of the central
nervous system. The objective of the present study was to determine
the effect of icv baclofen, a GABAB receptor agonist, on delayed GE
induced by dipyrone. Adult male Wistar rats received a saline test meal
containing phenol red as a marker. GE was indirectly evaluated by
determining the percent of gastric retention (%GR) of the meal 10 min
after orogastric administration. In the first experiment, the animals
were injected iv with vehicle (Civ) or 80 mg/kg (240 µmol/kg) dipy-
rone (Dpiv), followed by icv injection of 10 µl vehicle (bac0), or 0.5
(bac0.5), 1 (bac1) or 2 µg (bac2) baclofen. In the second experiment,
the animals were injected icv with 5 µl vehicle (Cicv) or an equal
volume of a solution containing 4 µmol (1333.2 µg) dipyrone (Dpicv),
followed by 5 µl vehicle (bac0) or 1 µg baclofen (bac1). GE was
determined 10 min after icv injection. There was no significant
difference between control animals from one experiment to another
concerning GR values. Baclofen at the doses of 1 and 2 µg significant-
ly reduced mean %GR induced by iv dipyrone (Dpivbac1 = 35.9% and
Dpivbac2 = 26.9% vs Dpivbac0 = 51.8%). Similarly, baclofen signifi-
cantly reduced the effect of dipyrone injected icv (mean %GR: Dpicvbac1
= 30.4% vs Dpicvbac0 = 54.2%). The present results suggest that
dipyrone induces delayed GE through a route in the central nervous
system that is blocked by the activation of GABAB receptors.
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Introduction
Gastric emptying consists of the transfer
of gastric content to the small bowel as a
result of the action of stimulating and inhib-
itory mechanisms that control the motor ac-
tivity of the stomach, pylorus and duode-
num. Under physiological conditions, gas-
tric emptying occurs in an appropriate man-
ner for the conditions of digestion and ab-
sorption present in the small bowel (1,2).
Intravenous (iv) and intracerebroventricu-
lar (icv) administration of dipyrone to rats
leads to a delay in gastric emptying of a liquid
meal (saline). This phenomenon is more in-
tense during the first hour after iv administra-
tion and is abolished by subdiaphragmatic va-
gotomy and electrolytic lesion of the hypotha-
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lamic paraventricular nucleus (3). These ob-
servations suggest that dipyrone influences
gastric emptying through the central nervous
system (CNS), leading to a predominance of
inhibitory mechanisms conveyed by the vagus
nerve on the motor activity of the stomach,
pylorus and/or duodenum. However, the neu-
rotransmitters possibly involved in the media-
tion of this effect are unknown.
Gamma-aminobutyric acid (GABA) is
the most important inhibitory neurotrans-
mitter in the CNS, where three different
receptors have been identified: GABAA,
GABAB and GABAC (4-7). GABAA recep-
tors show a predominantly postsynaptic lo-
calization and, when activated, lead to rapid
membrane hyperpolarization due to an in-
crease in Cl- channel conductance (4,5).
GABAC receptors are also associated with
Cl- channels, but differ from GABAA recep-
tors in terms of pharmacological, structural,
functional and genetic aspects and cellular
localization (6-8). Activation of GABAB re-
ceptors through Gi/Go membrane protein sig-
naling leads to the inhibition of adenylate
cyclase, increases K+ channel conductance,
and reduces Ca2+ channel conductance (5).
Studies using agonists and antagonists of
GABA receptors located in neurons of the
dorsal vagal complex (DVC) have provided
evidence that this acid is involved in the
control of gastrointestinal motility (9-13). In
particular, baclofen (ß-p-chlorophenyl-
GABA), a lipophilic derivative of GABA,
binds as a specific agonist to GABAB recep-
tors which, when activated, induce stimula-
tion of the gastric acid secretion and motor
activity of the stomach through the vagus
nerve (11,14-16).
The objective of the present study was to
test the hypothesis that activation of GABAB
receptors with icv baclofen inhibits delayed
gastric emptying induced by dipyrone in rats.
Material and Methods
Male Wistar rats weighing 250-300 g,
adapted to laboratory conditions for 2 weeks,
were used. The experimental protocols ap-
plied in the present study followed the rec-
ommendations of the Brazilian College of
Animal Experimentation. For surgical pro-
cedures, the animals were sedated by intra-
peritoneal injection of 75 mg/kg thiopental.
After the procedures, the animals were kept
in individual cages with ration and water
available ad libitum.
Solutions of dipyrone or baclofen (Sigma,
St. Louis, MO, USA) were prepared just
before administration using sterile saline
solution as vehicle, with dipyrone being pro-
tected from light. The iv or icv doses of
dipyrone have been described elsewhere (3).
Equivalent volumes of the vehicle were used
as control.
Eight days before the study, a 15-mm 21-
G stainless steel cannula was implanted into
the right lateral ventricle of each animal and
fixed to the skull with two screws, self-
polymerizing acrylic and instant adhesive
(cyanoacrylate ester). The cannulae were
implanted at the following coordinates in
relation to the bregma according to the atlas
of Groot (17): anteroposterior = -0.2 mm,
right lateral = 1.5 mm, vertical = 4.2 mm. For
microinjection, a 28-G internal cannula was
connected through polyethylene tubing to a
25-µl Hamilton syringe.
In the first experiment, animals were in-
jected iv through a caudal vein with vehicle
(Civ) or 80 mg/kg (240 µmol/kg) dipyrone
solution (Dpiv), followed by icv injection of
10 µl vehicle (bac0) or an equal volume of a
solution containing 0.5, 1 or 2 µg baclofen
(bac0.5, 1 and 2, respectively) over a period
of 30 s, with the animal remaining connected
to the system for an additional 30 s. Gastric
emptying was determined 10 min after re-
moval of the internal cannula.
In the second experiment, animals re-
ceived 5 µl of the vehicle (Cicv) or an equal
volume of a solution containing 4 µmol
(1333.2 µg) dipyrone (Dpicv) icv over a pe-
riod of 30 s, with the animal remaining con-
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nected to the system for an additional 30 s.
Using another injection system, the animals
received 5 µl vehicle (bac0) or an equal
volume of 1 µg baclofen solution (bac1)
over a period of 30 s, with the animal re-
maining connected to the system for an addi-
tional 30 s. Gastric emptying was deter-
mined 10 min after removal of the internal
cannula.
Gastric emptying was evaluated in the
animals between 14:00 and 17:00 h after a
24-h fast during which only water was avail-
able, and which was withdrawn at the time of
the test. The test meal consisted of 2 ml/100
g body weight of an aqueous 0.9% NaCl
solution containing 60 µg/ml phenol red as
marker. In all experiments, gastric emptying
was indirectly evaluated in non-sedated ani-
mals, except for the time of sacrifice, by
determining the percent of gastric retention
(%GR) of the phenol red-containing test meal
recovered within the gastric content 10 min
after orogastric administration of the meal
(18). Phenol red concentrations were meas-
ured with a spectrophotometer at 560 nm.
Higher icv doses of baclofen (≥1.5 µg/kg) in
rats have induced exploratory behavioral ef-
fects like grooming, gnawing and, in some
cases, rigid posture with extended limbs and
arched back (19). In the present study, the
baclofen doses ranged from 2 to ~8 µg/kg
and induced the reactions described above.
However, these reactions did not interfere
with the measurement of gastric emptying in
vivo.
At the end of the study, all animals were
sacrificed and injection into the lateral ven-
tricle was confirmed by administering 10 µl
of a 1% Evans blue solution through the
cannula. The brains were then removed and
fixed in 10% formalin for 24 h. Specimens
were then cut into coronal sections and icv
injection was confirmed when the dye was
detected in the fourth ventricle.
The gastric retention results are reported
as means ± SEM. ANOVA was used for
statistical analysis and pairs were compared
by the Tukey test (α = 0.05). The dose-
response effect of baclofen was determined
by calculation of the correlation coefficient
for ordered pairs (r).
Results
Figure 1 shows the results of the first
experiment in which iv administration of
dipyrone caused a significant increase in the
gastric retention of animals receiving ve-
hicle icv (bac0) compared to controls (mean
%GR: Dpivbac0 = 51.8 vs Civbac0 = 33.2%).
In contrast, no significant difference in gas-
tric retention was observed between the group
of animals receiving iv dipyrone followed by
1 and 2 µg icv baclofen (bac1 and bac2) and
its respective control group (mean %GR:
Dpivbac1 = 35.9 vs Civbac1 = 24.2% and
Dpivbac2 = 26.9 vs Civbac2 = 19.0%). There-
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Figure 1. Gastric retention of a saline test meal 10 min after orogastric administration to
rats. Eight days before the experiment, all animals were implanted with a stainless steel
cannula into the right lateral ventricle. The animals were injected iv with vehicle (C) or 80
mg/kg (240 µmol/kg) dipyrone (Dp), followed by icv injection through an internal cannula of
10 µl vehicle (bac0) or an equal volume of solution containing 0.5, 1 or 2 µg baclofen
(bac0.5, bac1 and bac2, respectively). Gastric retention, reported as mean ± SEM in
percent, was determined 10 min after removal of the internal cannula. The number of
animals in each group is given in parentheses. *P < 0.05 (Tukey test).
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fore, 1 and 2 µg doses of baclofen signifi-
cantly reduced gastric retention induced by
iv dipyrone (Dpivbac1 and Dpivbac2 vs
Dpivbac0). A strong negative correlation was
observed between the dose of baclofen and
gastric retention in animals receiving dipy-
rone (r = -0.97). Control animals injected iv
with vehicle also showed a negative correla-
tion between the dose of the GABAB agonist
and gastric retention (r = -0.92), with the
reduction in gastric retention being nonsig-
nificant, except for bac0.5 vs bac2 controls
(mean %GR: Civbac0.5 = 34.7 vs Civbac2 =
19.0%).
In the second experiment (Figure 2), icv
administration of 1 µg baclofen also signifi-
cantly reduced the effect of previous icv
injection of 4 µmol (1333.2 µg) dipyrone on
gastric retention of the test meal (mean %GR:
Dpicvbac1 = 30.4 vs Dpicvbac0 = 54.2%). No
significant difference in gastric retention was
observed between the control animals in-
jected icv with vehicle or baclofen (mean
%GR: Cicvbac1 = 26.3 vs Cicvbac0 = 29.5%).
Discussion
The mechanisms involved in the phe-
nomenon of delayed gastric emptying in-
duced by dipyrone in rats, or the site(s) of
action of the drug in the CNS, are unknown.
However, in the present study we showed
that icv administration of baclofen, a specif-
ic GABAB receptor agonist, abolished this
effect.
GABAA and GABAB receptors are dis-
tributed within the rat CNS at equivalent
concentrations in some areas, with a pre-
dominance of the former in most brain re-
gions and of the latter in some others (20,21).
In the CNS, activation of GABAB recep-
tors by baclofen results in the hyperpolariza-
tion of postsynaptic membranes or inhibi-
tion of the release of the neurotransmitter at
presynaptic terminals (5). Activation of post-
synaptic GABAB receptors leads to a pro-
longed increase in K+ channel conductance,
which is responsible for the generation of
slow inhibitory GABA-ergic events in the
CNS (4,5,22), including the modulation of
rhythmic hippocampal activity (23). Presyn-
aptic GABAB receptors are primarily in-
volved in the regulation of neurotransmitter
release, since the main effect of baclofen
consists of reducing the release of excitatory
and inhibitory synaptic transmitters (4,5).
This action of baclofen has been observed in
a variety of synapses, with the drug reducing
the release of noradrenaline, dopamine, ace-
tylcholine, serotonin, glutamate, and aspar-
tate. Presynaptic GABAB receptors may also
function as autoreceptors, reducing the re-
lease of GABA and thus diminishing the
postsynaptic inhibition mediated by the acti-
vation of GABAA receptors (22).
Since in a previous study (3) the effect of
dipyrone on gastric emptying could be abol-
ished by subdiaphragmatic vagotomy, we
may assume that the DVC is primarily in-
volved in this phenomenon. The DVC is
formed by the nucleus tractus solitarii whose
neurons receive information through the af-
ferent route and by the dorsal nucleus of the
vagus nerve, where cholinergic stimulating
and non-cholinergic, non-adrenergic inhibi-
tory motoneurons are located, whose axons
80
G
as
tr
ic
 r
et
en
tio
n 
(%
)
60
40
20
0
*
*
C Dp C Dp
bac0 bac1
icv
icv
Figure 2. Gastric retention of a
saline test meal 10 min after
orogastric administration to rats.
Eight days before the experi-
ment, all animals were im-
planted with a stainless steel
cannula into the right lateral ven-
tricle. The animals were injected
icv through an internal cannula
with 5 µl vehicle (C) or an equal
volume of solution containing 4
µmol (1333.2 µg) dipyrone (Dp),
followed by injection of 5 µl ve-
hicle (bac0) or an equal volume
of solution containing 1 µg
baclofen (bac1). Gastric reten-
tion, reported as mean ± SEM in
% for N = 8 animals, was deter-
mined 10 min after removal of
the internal cannula. *P < 0.01
(Tukey test).
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correspond to the efferent route of the vagus
nerve (2).
In the rat, GABAB receptors are located
predominantly at presynaptic afferent termi-
nals of the vagus nerve, which project into
the nucleus tractus solitarii, although evi-
dence also indicates a postsynaptic location
in this nucleus (24).
One may speculate that the phenomenon
of delayed gastric emptying induced by di-
pyrone is the result of activation of a route
that stimulates inhibitory motoneurons and/
or inhibits excitatory motoneurons of the
vagus nerve. Since there is strong evidence
that GABA plays a role in the control of
gastric motility at the level of the DVC (9,11-
13), activation of presynaptic GABAB re-
ceptors by baclofen that leads to the block-
ade of excitation of a non-cholinergic, non-
adrenergic route and/or blockade of the inhi-
bition of a cholinergic route might explain
the results observed in the present study.
However, in addition to the possible in-
volvement of the DVC which also influ-
ences gastric motility, a role of GABA in
other nearby nuclei such as the nucleus
ambiguus and nucleus raphe obscurus has
been demonstrated (9,25). GABA receptors
have also been identified in the hypothalam-
ic paraventricular nucleus (26,27), which
shows connections with the DVC and, when
lesioned electrolytically, blocks the effect of
dipyrone (3). In addition, the DVC is under
the influence of other regions of the CNS
that interfere with gastric motility, such as
the central nucleus of the amygdala and the
insular cortex, where GABA receptors have
also been identified (20,21,28-31).
Based on the evidence showing a more
extensive effect of dipyrone on the CNS, an
anticonvulsant effect of this drug has been
demonstrated in various experimental rat
models of epilepsy. Different hypotheses to
explain this effect have been proposed, such
as the inhibition of prostaglandin produc-
tion, blockade of the inactivation of adeno-
sine (a potent inhibitory neuromodulator),
activation of GABAA receptors, and an
antiglutamatergic effect (32,33). Finally, an
extrasynaptic presence of GABAB receptors
has been proposed, although for these recep-
tors to be activated continuously, elevated
concentrations of GABA in the extracellular
fluid are necessary or its concentration needs
to be increased close to these receptors
through the release from various neurons
(4,23,34).
Thus, it is possible that various CNS
structures and mediators are involved which,
when activated, express the effect of dipy-
rone on gastric emptying, in addition to sites
for the blockade of this effect by baclofen.
In the first experiment, although no sta-
tistically significant difference was observed
between Civbac0 and the other baclofen con-
trols, gastric emptying tended to be decreased
following this agonist. This observation sug-
gests that icv baclofen may have an effect on
this gastric function per se. Nevertheless,
this drug had a marked and statistically sig-
nificant inhibitory effect on the dipyrone-
induced delay of gastric emptying. The re-
duction of the effect of iv dipyrone adminis-
tration followed by 1 and 2 µg icv baclofen
was slightly higher (a 31% reduction in mean
GR in the Dpivbac1 group and a 48% reduc-
tion in the Dpivbac2 group compared to the
Dpivbac0 group) than that observed in the
respective controls (a 27% reduction in mean
GR in the Civbac1 group and a 42% reduc-
tion in the Civbac2 group compared to the
Civbac0 group). Taken together, these results
suggest that these two drugs have opposite
effects on the CNS through independent
mechanisms.
The results of the second experiment sup-
ported more convincingly the view that
baclofen blocks a route that is required for
the effect of dipyrone in the CNS. Baclofen
induced a 4-fold reduction in the effect of
dipyrone on gastric retention (a 44% reduc-
tion in mean GR for the Dpicvbac1 group
compared to the Dpicvbac0 group) compared
to that observed in the respective control (an
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11% reduction in mean GR for the Cicvbac1
group compared to the Cicvbac0 group).
 The present results suggest that dipy-
rone induces delayed gastric emptying
through a route in the CNS that is blocked by
the activation of GABAB receptors.
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